BRAWLEY OTIS W — SEC Form 4 filings
SEC reporting owner CIK 1213029. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-19 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 35,640 shares, $19,958 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 35,640 shares @ $0.56 ($19,958) in Lyell Immunopharma, Inc., filed 2025-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | Director | 4 | 1 leg · 35,640 sh · $19,958 | — | 3 |
| AGILENT TECHNOLOGIES, INC. (A) | Director | 3 | — | — | 6 |
| INCYTE CORP (INCY) | Director | 3 | — | — | 6 |
| PDS Biotechnology Corp (PDSB) | Director | 3 | — | — | 3 |
Form 4 filings — BRAWLEY OTIS W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 9,250 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | INCYTE CORP (INCY) | Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 2,158 @ $111.75 · Grant/award (A): 888 @ $111.75 | EDGAR |
| 2026-03-03 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 54,876 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Lyell Immunopharma, Inc. (LYEL) | Purchase (P): 35,640 @ $0.56 | EDGAR |
| 2025-03-18 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,819 @ $121.18 · Grant/award (A): 812 @ $121.18 | EDGAR |
| 2024-06-25 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,830 @ $0 · Grant/award (A): 12,517 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,678 @ $147.48 · Grant/award (A): 750 @ $147.48 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1213029 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →